A Map of Human Type 1 Diabetes Progression by Imaging Mass Cytometry.

Cell Metab 2019 Mar 31;29(3):755-768.e5. Epub 2019 Jan 31.

Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland. Electronic address:

Type 1 diabetes (T1D) results from the autoimmune destruction of insulin-producing β cells. A comprehensive picture of the changes during T1D development is lacking due to limited sample availability, inability to sample longitudinally, and the paucity of technologies enabling comprehensive tissue profiling. Here, we analyzed 1,581 islets from 12 human donors, including eight with T1D, using imaging mass cytometry (IMC). IMC enabled simultaneous measurement of 35 biomarkers with single-cell and spatial resolution. We performed pseudotime analysis of islets through T1D progression from snapshot data to reconstruct the evolution of β cell loss and insulitis. Our analyses revealed that β cell destruction is preceded by a β cell marker loss and by recruitment of cytotoxic and helper T cells. The approaches described herein demonstrate the value of IMC for improving our understanding of T1D pathogenesis, and our data lay the foundation for hypothesis generation and follow-on experiments.

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15504131183069
Publisher Site
http://dx.doi.org/10.1016/j.cmet.2018.11.014DOI Listing
March 2019
26 Reads

Publication Analysis

Top Keywords

imaging mass
8
type diabetes
8
mass cytometry
8
t1d
5
described demonstrate
4
cytometry imc
4
imc imc
4
imc enabled
4
approaches described
4
biomarkers single-cell
4
single-cell spatial
4
t cells approaches
4
measurement biomarkers
4
t1d imaging
4
simultaneous measurement
4
enabled simultaneous
4
donors including
4
preceded cell
4
analyzed 1581
4
improving understanding
4

Similar Publications